341 related articles for article (PubMed ID: 32006723)
21. Bacillus Calmette-Guérin (BCG) vaccine adverse events in Victoria, Australia: analysis of reports to an enhanced passive surveillance system.
Clothier HJ; Hosking L; Crawford NW; Russell M; Easton ML; Quinn JA; Buttery JP
Drug Saf; 2015 Jan; 38(1):79-86. PubMed ID: 25475539
[TBL] [Abstract][Full Text] [Related]
22. [Modern microbiological methods in diagnosis of adverse reactions after BCG vaccination. Case reports].
Zwolska Z; Augustynowicz-Kopeć E; Zabost A; Ziółkowski J; Buchwald J; Płończak M; Walas W; Ziebiński M
Pneumonol Alergol Pol; 2004; 72(11-12):505-11. PubMed ID: 16329351
[TBL] [Abstract][Full Text] [Related]
23. Differential diagnosis of primary immunodeficiency in patients with BCGitis and BCGosis: A single-centre study.
Soyak Aytekin E; Keskin A; Tan C; Yalçın E; Dogru D; Ozcelik U; Kiper N; Tezcan I; Cagdas D
Scand J Immunol; 2021 Oct; 94(4):e13084. PubMed ID: 34780073
[TBL] [Abstract][Full Text] [Related]
24. Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada.
Deeks SL; Clark M; Scheifele DW; Law BJ; Dawar M; Ahmadipour N; Walop W; Ellis CE; King A
Pediatr Infect Dis J; 2005 Jun; 24(6):538-41. PubMed ID: 15933565
[TBL] [Abstract][Full Text] [Related]
25. Molecular confirmation of Bacillus Calmette Guerin vaccine related adverse events among Saudi Arabian children.
Al-Hajoj S; Memish Z; Abuljadayel N; AlHakeem R; AlRabiah F; Varghese B
PLoS One; 2014; 9(11):e113472. PubMed ID: 25409184
[TBL] [Abstract][Full Text] [Related]
26. Assistance of next-generation sequencing for diagnosis of disseminated Bacillus Calmette-Guerin disease with X-SCID in an infant: a case report and literature review.
Zhang H; Liao Y; Zhu Z; Liu H; Li D; Wang S
Front Cell Infect Microbiol; 2024; 14():1341236. PubMed ID: 38410723
[No Abstract] [Full Text] [Related]
27. Disseminated Bacillus Calmette-Guerin infection after BCG vaccination.
Rezai MS; Khotaei G; Mamishi S; Kheirkhah M; Parvaneh N
J Trop Pediatr; 2008 Dec; 54(6):413-6. PubMed ID: 18593737
[TBL] [Abstract][Full Text] [Related]
28. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children.
Hesseling AC; Rabie H; Marais BJ; Manders M; Lips M; Schaaf HS; Gie RP; Cotton MF; van Helden PD; Warren RM; Beyers N
Clin Infect Dis; 2006 Feb; 42(4):548-58. PubMed ID: 16421800
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of bacille Calmette-Guérin immunisation programs in Australia.
Khandaker G; Beard FH; Dey A; Coulter C; Hendry AJ; Macartney KK
Commun Dis Intell Q Rep; 2017 Mar; 41(1):E33-E48. PubMed ID: 28385137
[TBL] [Abstract][Full Text] [Related]
30. A case of Mycobacterium bovis Bacillus Calmette-Guérin (BCG) strain meningitis and ventriculitis following BCG vaccination.
Furuichi M; Mori F; Uejima Y; Sato S; Kurihara J; Kawano Y; Suganuma E
Int J Infect Dis; 2020 Nov; 100():373-376. PubMed ID: 32976992
[TBL] [Abstract][Full Text] [Related]
31. Safety and Immunogenicity of Early Bacillus Calmette-Guérin Vaccination in Infants Who Are Preterm and/or Have Low Birth Weights: A Systematic Review and Meta-analysis.
Badurdeen S; Marshall A; Daish H; Hatherill M; Berkley JA
JAMA Pediatr; 2019 Jan; 173(1):75-85. PubMed ID: 30476973
[TBL] [Abstract][Full Text] [Related]
32. First vaccination after birth: serious adverse events of Bacillus Calmette-Guérin (BCG) in real-world.
Lu J; Zhang X; Xu H; Li Z
Hum Vaccin Immunother; 2022 Nov; 18(5):2080443. PubMed ID: 35687363
[TBL] [Abstract][Full Text] [Related]
33. Disseminated bacille Calmette-Guérin in Iranian children with severe combined immunodeficiency.
Sadeghi-Shabestari M; Rezaei N
Int J Infect Dis; 2009 Nov; 13(6):e420-3. PubMed ID: 19403320
[TBL] [Abstract][Full Text] [Related]
34. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
Fu H; Lin HH; Hallett TB; Arinaminpathy N
Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270
[TBL] [Abstract][Full Text] [Related]
35. Inborn Errors of Immunity in Patients with Adverse Events Following BCG Vaccination in Brazil.
Lyra PT; Souza E; Moura ACA; Matta MC; Torres LC; Coelho AVC; Rocha MÂW; Arraes L; Oliveira JB
J Clin Immunol; 2022 Nov; 42(8):1708-1720. PubMed ID: 35907101
[TBL] [Abstract][Full Text] [Related]
36. Bacillus Calmette-Guérin infection after vaccination of human immunodeficiency virus-infected children.
Besnard M; Sauvion S; Offredo C; Gaudelus J; Gaillard JL; Veber F; Blanche S
Pediatr Infect Dis J; 1993 Dec; 12(12):993-7. PubMed ID: 8108227
[TBL] [Abstract][Full Text] [Related]
37. [BCG vaccine administration schedule and primary immunodeficiencies: Is it time for a change?].
Sotomayor F C; Palma B J
Rev Chil Pediatr; 2019 Dec; 90(6):668-674. PubMed ID: 32186591
[TBL] [Abstract][Full Text] [Related]
38. Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency.
Al-Hammadi S; Alsuwaidi AR; Alshamsi ET; Ghatasheh GA; Souid AK
BMC Res Notes; 2017 May; 10(1):177. PubMed ID: 28476145
[TBL] [Abstract][Full Text] [Related]
39. [HIV-infection, AIDS and BCG vaccination].
Toida I
Kekkaku; 1993 Jun; 68(6):435-44. PubMed ID: 8341039
[TBL] [Abstract][Full Text] [Related]
40. Mycobacterium bovis (Bacille Calmette-Guérin) bacteremia in immunocompetent neonates following vaccination.
Thamthitiwat S; Marin N; Baggett HC; Peruski LF; Kiatkulwiwat W; Panumatrasmee V; Varma JK; Nateniyom S; Akarasewi P; Maloney SA
Vaccine; 2011 Feb; 29(9):1727-30. PubMed ID: 21215347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
